Xerostomia and treatment with ddI.
D016049:Didanosine / Q000009:adverse effects* / Q000627:therapeutic use; D006679:HIV Seropositivity / Q000188:drug therapy*; D006801:Humans; D012463:Saliva / Q000187:drug effects / Q000378:metabolism; D014987:Xerostomia / Q000139:chemically induced*
D016049:Didanosine